Long-Term Follow-Up of Children With Congenital Hyperinsulinism on Octreotide Therapy

---

Copy For Citation

Demirbilek H., Shah P., Arya V. B., Hinchey L., Flanagan S. E., Ellard S., ...More

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, vol.99, no.10, pp.3660-3667, 2014 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 99 Issue: 10
• Publication Date: 2014
• Doi Number: 10.1210/jc.2014-1866
• Journal Name: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.3660-3667
• Hacettepe University Affiliated: Yes

Abstract

Context: Octreotide, a somatostatin analog, is commonly used in diazoxide unresponsive congenital hyperinsulinism (CHI) patients as a second-line therapy.